Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Thalmann

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Hearing Research|February 1, 1982
Effect of substrate-free vascular perfusion upon cochlear potentials and glycogen of the stria vascularisJ Kambayashi, T Kobayashi, J E DeMott, et al.
Hearing Research|May 1, 1982
Minimal concentrations of metabolic substrates capable of supporting cochlear potentialsJ Kambayashi, T Kobayashi, N Y Marcus, et al.
Journal of Structural Biology|August 18, 2000
The otoconia of the guinea pig utricle: internal structure, surface exposure, and interactions with the filament matrixU Lins, M Farina, M Kurc, et al.
The Laryngoscope|March 1, 1987
Composition and supramolecular organization of the tectorial membraneI Thalmann, G Thallinger, E C Crouch, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2Y Wang, P E Kowalski, I Thalmann, et al.
Genomics|June 10, 1995
cDNA cloning, tissue distribution, and chromosomal localization of Ocp2, a gene encoding a putative transcription-associated factor predominantly expressed in the auditory organsH Chen, I Thalmann, J C Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Hearing Research|February 1, 1982
Effect of substrate-free vascular perfusion upon cochlear potentials and glycogen of the stria vascularisJ Kambayashi, T Kobayashi, J E DeMott, et al.
Hearing Research|May 1, 1982
Minimal concentrations of metabolic substrates capable of supporting cochlear potentialsJ Kambayashi, T Kobayashi, N Y Marcus, et al.
Journal of Structural Biology|August 18, 2000
The otoconia of the guinea pig utricle: internal structure, surface exposure, and interactions with the filament matrixU Lins, M Farina, M Kurc, et al.
The Laryngoscope|March 1, 1987
Composition and supramolecular organization of the tectorial membraneI Thalmann, G Thallinger, E C Crouch, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2Y Wang, P E Kowalski, I Thalmann, et al.
Genomics|June 10, 1995
cDNA cloning, tissue distribution, and chromosomal localization of Ocp2, a gene encoding a putative transcription-associated factor predominantly expressed in the auditory organsH Chen, I Thalmann, J C Adams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†G von Minckwitz, S Loibl, M Untch, et al.
Pageof 6